Evidence map›Paper›PMID 34665406›Full record

ArticleMolecular neurobiology2022

Melatonin Pretreatment Protects Against Status epilepticus, Glutamate Transport, and Oxidative Stress Induced by Kainic Acid in Zebrafish.

Ana Caroline Salvador de Farias, Karolyne de Pieri Pickler, Henrique Teza Bernardo, Samira Leila Baldin, Eduardo Ronconi Dondossola, Eduardo Pacheco Rico

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Caroline Salvador de FariasTranslational Psychiatry Laboratory, Laboratory of Translational Biomedicine Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
Karolyne de Pieri PicklerTranslational Psychiatry Laboratory, Laboratory of Translational Biomedicine Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
Henrique Teza BernardoTranslational Psychiatry Laboratory, Laboratory of Translational Biomedicine Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
Samira Leila BaldinTranslational Psychiatry Laboratory, Laboratory of Translational Biomedicine Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
Eduardo Ronconi DondossolaTranslational Psychiatry Laboratory, Laboratory of Translational Biomedicine Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
Eduardo Pacheco RicoTranslational Psychiatry Laboratory, Laboratory of Translational Biomedicine Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil. eduprico@gmail.com.ORCID http://orcid.org/0000-0003-0019-328X
Universidade do Sul de Santa Catarina · BR

Funding

conselho nacional de desenvolvimento científico e tecnológico Universal 429302/2018-5coordenação de aperfeiçoamento de pessoal de nível superior CAPES AUXPE PROEX N. 23038.020053/2018-52fundação de amparo à pesquisa e inovação do estado de santa catarina FAPESC - Universal 12/2020
6 · The paper itself

Abstract

Status epilepticus (SE) develops from abnormal electrical discharges, resulting in neuronal damage. Current treatments include antiepileptic drugs. However, the most common drugs used to treat seizures may sometimes be ineffective and have many side effects. Melatonin is an endogenous physiological hormone that is considered an alternative treatment for neurological disorders because of its free radical scavenging property. Thus, this study aimed to determine the effects of melatonin pretreatment on SE by inducing glutamatergic hyperstimulation in zebrafish. Seizures were induced in zebrafish using kainic acid (KA), a glutamate analog, and the seizure intensity was recorded for 60 min. Melatonin treatment for 7 days showed a decrease in seizure intensity (28%), latency to reach score 5 (14 min), and duration of SE (29%). In addition, melatonin treatment attenuated glutamate transporter levels, which significantly decreased in the zebrafish brain after 12 h of KA-induced seizures. Melatonin treatment reduced the increase in oxidative stress by reactive oxygen species formation through thiobarbituric acid reactive substances and 2',7'-dichiorofluorescin, induced by KA-seizure. An imbalance of antioxidant enzyme activities such as superoxide dismutase and catalase was influenced by melatonin and KA-induced seizures. Our study indicates that melatonin promotes a neuroprotective response against the epileptic profile in zebrafish. These effects could be related to the modulation of glutamatergic neurotransmission, recovery of glutamate uptake, and oxidative stress parameters in the zebrafish brain.

Indexed as

Amino Acid Transport System X-AGAnimalsAntioxidantsCatalaseGlutamic AcidGlutathioneKainic AcidMelatoninNeuronsNeuroprotective AgentsOxidative StressReactive Oxygen SpeciesStatus EpilepticusSuperoxide DismutaseZebrafishAmino Acid Transport System X-AGAntioxidantsCatalaseGlutamic AcidGlutathioneKainic AcidMelatoninNeuroprotective AgentsReactive Oxygen SpeciesSuperoxide DismutaseEpilepsyGlutamateMelatoninOxidative stressZebrafish

Identifiers

PMID34665406
OpenAlexW3171576726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.